Loading stock data…
BCPC
$162.32+3.63 (+2.29%)
After Hours$162.32+0.00 (+0.00%)· Last close Jun 9
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Balchem Corporation in the Basic Materials sector is trading at $162.32. Wall Street consensus targets $200.75 (4 analysts), implying a +23.7% move over the next 12 months. The stock is currently 12% below its 52-week high of $183.90, remaining 0.6% above its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +23.7% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$162.32
Potential Downside
0%
Whystock Fair Value$162.32
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus4 analysts
Mean target$200.75+23.7%
Range$164.00 – $234.00
Fundamentals
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It o...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.59%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.30%
Volume
Today's trading volume
186,563
Recent News
Are Options Traders Betting on a Big Move in Balchem Stock?
Investors need to pay close attention to BCPC stock based on the movements in the options market lately.
Should Balchem’s Q1 2026 Earnings Jump and Buyback Activity Require Action From Balchem (BCPC) Investors?
In the first quarter of 2026, Balchem Corporation reported higher sales of US$270.71 million and net income of US$40.29 million year over year, while also completing a share repurchase of 159,539 shares for US$25.85 million under its December 2025 buyback program. The combination of earnings growth and disciplined capital returns via the buyback underscores how Balchem is using improving profitability to support shareholder-focused capital allocation. Next, we’ll examine how Balchem’s...
Investment Firm Sells $12.2 Million Worth of Materials Stock, According to Latest SEC Filing
Trex Company is a leading provider of composite decking and outdoor living products for residential and commercial markets.
Here’s Why Investors Favored Balchem Corp. (BCPC)
Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter is available to download here. The first quarter of 2026 started with optimism about the domestic economy and attractive small-cap valuations, but it was affected by volatility due to geopolitical unrest in the Middle East and shifting expectations […]
Balchem Corporation Q1 2026 Earnings Call Summary
Moby summary of Balchem Corporation's Q1 2026 earnings call